Allan Flyvbjerg

发表

Reduced free IGF-I and increased IGFBP-3 proteolysis in Turner syndrome: modulation by female sex steroids.

H. Orskov, J. Frystyk, C. Gravholt, 2001, American journal of physiology. Endocrinology and metabolism.

Adiponectin and Peak Bone Mass in Men: A Cross-Sectional, Population-Based Study

M. Frost, J. Frystyk, A. Flyvbjerg, 2010, Calcified Tissue International.

1,25-Dihydroxyvitamin D3 stimulates the production of insulin-like growth factor-binding proteins-2, -3 and -4 in human bone marrow stromal cells.

A. Flyvbjerg, E. Eriksen, M. Kveiborg, 2001, European journal of endocrinology.

Changes in muscle size and MHC composition in response to resistance exercise with heavy and light loading intensity.

M. Kjaer, P. Aagaard, J. Andersen, 2008, Journal of applied physiology.

Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men.

J. Frystyk, A. Flyvbjerg, M. Andersen, 2009, The Journal of clinical endocrinology and metabolism.

Relationship of adiposity with arterial stiffness as mediated by adiponectin in older men and women: the Hoorn Study.

J. Dekker, M. Snijder, J. Frystyk, 2009, European journal of endocrinology.

Testosterone therapy decreases subcutaneous fat and adiponectin in aging men.

D. Hougaard, K. Højlund, J. Frystyk, 2012, European journal of endocrinology.

Insulin-like growth factor I - a novel biomarker of abdominal aortic aneurysms.

J. Frystyk, S. Urbonavičius, J. Lindholt, 2011, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

Effects of transdermal estrogen on collagen turnover at rest and in response to exercise in postmenopausal women.

H. Langberg, M. Kjær, J. Frystyk, 2012, Journal of applied physiology.

Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men

Jeroen J. Bax, H. Lamb, M. Lubberink, 2011, Cardiovascular diabetology.

Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men

H. Lamb, M. Lubberink, J. Frystyk, 2011, Cardiovascular diabetology.

Low adiponectin levels at baseline and decreasing adiponectin levels over 10 years of follow-up predict risk of the metabolic syndrome.

J. Jensen, J. Frystyk, M. Bjerre, 2017, Diabetes & metabolism.

Plasma (cid:1) -Defensin Is Associated with Cardiovascular Morbidity and Mortality in Type 1 Diabetic Patients

H. Parving, L. Tarnow, J. Frystyk, 2008 .

Reduced plasma adiponectin concentrations may contribute to impaired insulin activation of glycogen synthase in skeletal muscle of patients with type 2 diabetes

K. Højlund, H. Beck-Nielsen, J. Frystyk, 2006, Diabetologia.